Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Bone Biologics (BBLGW) Gains from Sales and Divestitures (2016)

Bone Biologics (BBLGW) has disclosed Gains from Sales and Divestitures for 1 consecutive years, with -$791139.0 as the latest value for Q4 2016.

  • Quarterly Gains from Sales and Divestitures changed N/A to -$791139.0 in Q4 2016 from the year-ago period, while the trailing twelve-month figure was -$791139.0 through Dec 2016, changed N/A year-over-year, with the annual reading at -$791139.0 for FY2016, N/A changed from the prior year.
  • Gains from Sales and Divestitures for Q4 2016 was -$791139.0 at Bone Biologics.
  • The five-year high for Gains from Sales and Divestitures was -$791139.0 in Q4 2016, with the low at -$791139.0 in Q4 2016.